Ghrelin and des-acyl ghrelin inhibit aromatase expression and activity in human adipose stromal cells: Suppression of cAMP as a possible mechanism

Breast Cancer Research and Treatment

Volumn 147, Issue 1, 2014, Pages 193-201

  Docanto, Maria M ^a   Yang, Fangyuan ^a   Callaghan, Brid ^b   Au, CheukMan C ^a,c   Ragavan, Rahini ^a,c   Wang, Xuyi ^a,c   Furness, John B ^b   Andrews, Zane B ^c   Brown, Kristy A ^a,c  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Adipose; Aromatase; Breast cancer; Des acyl ghrelin; Estrogens; Ghrelin

Indexed keywords

ANGIOTENSIN II; AROMATASE; CAPROMORELIN; CYCLIC AMP; DES ACYL GHRELIN; G PROTEIN COUPLED RECEPTOR; GHRELIN; GHRELIN RECEPTOR; MESSENGER RNA; OBESTATIN; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; CALCIUM; GHRELIN, DES-N-OCTANOYL; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADIPOSE STROMAL CELL; ADIPOSE TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION; SIGNAL TRANSDUCTION; STROMA CELL; WESTERN BLOTTING; AGONISTS; BREAST; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; AROMATASE; BLOTTING, WESTERN; BREAST; CALCIUM; CELLS, CULTURED; CYCLIC AMP; FEMALE; GHRELIN; HUMANS; PIPERIDINES; PYRAZOLES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GHRELIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 84906044357     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3060-1     Document Type: Article

References (48)

1. Brown KA, Simpson ER (2012) Obesity and breast cancer: mechanisms and therapeutic implications. Front Biosci (Elite Ed) 4:2515-2524
2. Simpson ER, Brown KA (2011) Obesity, aromatase and breast cancer. Expert Rev Endocrinol Metab 6(3):383-395
3. Brown KA, McInnes KJ, Hunger NI, Oakhill JS, Steinberg GR, Simpson ER (2009) Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res 69(13):5392-5399
4. Brown KA, Samarajeewa NU, Simpson ER (2013) Endocrine-related cancers and the role of AMPK. Mol Cell Endocrinol 366(2):170-9. doi:10.1016/j.mce.2012.06. 016
5. Brown KA, Simpson ER (2010) Obesity and breast cancer: progress to understanding the relationship. Cancer Res 70(1):4-7
6. Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Su E, Marsh E, Hakim A, Yin P, Ishikawa H, Amin S, Imir G, Gurates B, Attar E, Reierstad S, Innes J, Lin Z (2007) Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol 106(1-5):81-96. doi:10.1016/j.jsbmb.2007.05.027
7. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
8. Pazos Y, Casanueva FF, Camiña JP (2008) Basic aspects of ghrelin action. Vitam Horm 77:89-119
9. Seim I, Walpole C, Amorim L, Josh P, Herington A, Chopin L (2011) The expanding roles of the ghrelin-gene derived peptide obestatin in health and disease. Mol Cell Endocrinol 340(1):111-117. doi:10.1016/j.mce.2011.03.018
10. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 105:6320-6325
11. Howard AD, Feighner SD, Cully DF et al (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
12. Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85:495-522
13. Muccioli G, Baragli A, Granata R, Papotti M, Ghigo E (2007) Heterogeneity of ghrelin/growth hormone secretagogue receptors. Neuroendocrinology 86:147-164
14. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762):656-660
15. Matsumoto M, Hosoda H, Kitajima Y, Morozumi N, Minamitake Y, Tanaka S, Matsuo H, Kojima M, Hayashi Y, Kangawa K (2001) Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochemical and biophysical research communications 287(1):142-146. doi:10.1006/bbrc.2001.5553
16. Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85(2):495-522. doi:10.1152/physrev.00012.2004
17. Scerif M, Goldstone AP, Korbonits M (2011) Ghrelin in obesity and endocrine diseases. Mol Cell Endocrinol 340(1):15-25
18. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER (1981) Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53(2):412-417
19. Lephart ED, Simpson ER (1991) Assay of aromatase activity. Methods Enzymol 206:477-483
20. Callaghan B, Hunne B, Hirayama H, Sartor DM, Nguyen TV, Abogadie FC, Ferens D, McIntyre P, Ban K, Baell J, Furness JB, Brock JA (2012) Sites of action of ghrelin receptor ligands in cardiovascular control. Am J Physiol Heart Circ Physiol 303(8):1011-1021. doi:10.1152/ajpheart.00418.2012
21. Zhao Y, Agarwal VR, Mendelson CR, Simpson ER (1996) Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137(12):5739-5742
22. Subbaramaiah K, Morris PG, Zhou XK, Morrow M, Du B, Giri D, Kopelovich L, Hudis CA, Dannenberg AJ (2012) Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2(4):356-365. doi:10.1158/2159-8290.CD-11-0241
23. Callaghan B, Kosari S, Pustovit RV, Sartor DM, Ferens DP, Ban K, Baell J, Nguyen TV, Rivera LR, Brock JA, Furness JB (2013) Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor. Br J Pharmacol 171:1275-1286
24. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709
25. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87(1):240-244. doi:10.1210/jcem.87.1.8129
26. Grönberg M, Fjällskog M-L, Jirström K, Janson ET (2012) Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Acta Oncol 51(3):386-393. doi:10.3109/0284186X.2011.631576
27. Rauh M, Groschl M, Rascher W (2007) Simultaneous quantification of ghrelin and desacyl-ghrelin by liquid chromatography-tandem mass spectrometry in plasma, serum, and cell supernatants. Clin Chem 53(5):902-910. doi:10.1373/clinchem.2006.078956
28. Laviano A, Molfino A, Rianda S, Rossi Fanelli F (2012) The growth hormone secretagogue receptor (Ghs-R). Curr Pharm Des 18(31):4749-4754
29. Porporato PE, Filigheddu N, Reano S, Ferrara M, Angelino E, Gnocchi VF, Prodam F, Ronchi G, Fagoonee S, Fornaro M, Chianale F, Baldanzi G, Surico N, Sinigaglia F, Perroteau I, Smith RG, Sun Y, Geuna S, Graziani A (2013) Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 123(2):611-622. doi:10.1172/JCI39920
30. Reano S, Graziani A, Filigheddu N (2014) Acylated and unacylated ghrelin administration to blunt muscle wasting. Curr Opin Clin Nutr Metab Care 17(3):236-240. doi:10.1097/MCO.0000000000000049
31. Togliatto G, Trombetta A, Dentelli P, Cotogni P, Rosso A, Tschop MH, Granata R, Ghigo E, Brizzi MF (2013) Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression. J Am Heart Assoc 2(6):e000376. doi:10.1161/JAHA.113.000376
32. Benso A, St-Pierre DH, Prodam F, Gramaglia E, Granata R, van der Lely AJ, Ghigo E, Broglio F (2012) Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol 166(5):911-916. doi:10.1530/EJE-11-0982
33. Granata R, Volante M, Settanni F, Gauna C, Ghe C, Annunziata M, Deidda B, Gesmundo I, Abribat T, van der Lely AJ, Muccioli G, Ghigo E, Papotti M (2010) Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. J Mol Endocrinol 45(1):9-17. doi:10.1677/JME-09-0141
34. Togliatto G, Trombetta A, Dentelli P, Baragli A, Rosso A, Granata R, Ghigo D, Pegoraro L, Ghigo E, Brizzi MF (2010) Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 59(4):1016-1025. doi:10.2337/db09-0858
35. Dezaki K, Damdindorj B, Sone H, Dyachok O, Tengholm A, Gylfe E, Kurashina T, Yoshida M, Kakei M, Yada T (2011) Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet beta-cells. Diabetes 60(9):2315-2324. doi:10.2337/db11-0368
36. Park S, Jiang H, Zhang H, Smith RG (2012) Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc Natl Acad Sci USA 109(46):19003-19008. doi:10.1073/pnas.1209590109
37. Samarajeewa NU, Docanto MM, Simpson ER, Brown KA (2013) CREB-regulated transcription co-activator family stimulates promoter II-driven aromatase expression in preadipocytes. Horm Cancer 4(4):233-241. doi:10.1007/s12672-013- 0142-1
38. Michael MD, Michael LF, Simpson ER (1997) A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene. Mol Cell Endocrinol 134(2):147-156
39. Sofi M, Young MJ, Papamakarios T, Simpson ER, Clyne CD (2003) Role of CRE-binding protein (CREB) in aromatase expression in breast adipose. Breast Cancer Res Treat 79(3):399-407
40. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, Zhou XK, Blaho VA, Hla T, Yang P, Kopelovich L, Hudis CA, Dannenberg AJ (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) 4(3):329-346. doi:10.1158/1940- 6207CAPR-10-0381
41. Riemsma R, Forbes CA, Kessels A, Lykopoulos K, Amonkar MM, Rea DW, Kleijnen J (2010) Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer. Breast Cancer Res Treat 123(1):9-24. doi:10.1007/s10549-010-0974-0
42. Schmid SM, Eichholzer M, Bovey F, Myrick ME, Schotzau A, Guth U (2012) Impact of body mass index on compliance and persistence to adjuvant breast cancer therapy. Breast 21(4):487-492. doi:10.1016/j.breast.2011.11.005
43. Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, Sasano H (2005) Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer 12(4):701-720. doi:10.1677/erc.1.00834
44. Cassoni P, Papotti M, Ghè C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E, Muccioli G (2001) Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86:1738-1745
45. Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, Francis GD, Herington AC, Chopin LK (2005) Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer 12:839-850
46. Fung JN, Seim I, Wang D, Obermair A, Chopin LK, Chen C (2010) Expression and in vitro functions of the ghrelin axis in endometrial cancer. Horm Cancer 1(5):245-255. doi:10.1007/s12672-010-0047-1
47. Delhanty PJ, Huisman M, Baldeon-Rojas LY, van den Berge I, Grefhorst A, Abribat T, Leenen PJ, Themmen AP, van der Lely AJ (2013) Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. FASEB J 27(4):1690-1700. doi:10.1096/fj.12-221143
48. Julien M, Kay RG, Delhanty PJ, Allas S, Granata R, Barton C, Constable S, Ghigo E, van der Lely AJ, Abribat T (2012) In vitro and in vivo stability and pharmacokinetic profile of unacylated ghrelin (UAG) analogues. Eur J Pharm Sci 47(4):625-635. doi:10.1016/j.ejps.2012.07.014